Australia, Jan. 15 -- SCT Cell Manufacturing s.r.o., owns the trademark (2554488) for 'SCTBIO' till June 6, 2035.
Status: registered:
Registered/protected
Classes: 40 [Manufacture of cell therapy materials to the order and specification of others including filling; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies to the order and specification of others.] and 42 [Pharmaceutical research and development, namely for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies; scientific research and development, namely for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies; consultation in the field of pharmaceutical research and development, namely for cell therapy material materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies; product research and development, namely for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies; biological materials testing services and biological laboratory services, namely for cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies; contract research services in the field of cell therapy materials, cellular vaccines, car-t therapies, tcr-t therapies, or car-nk therapies.]
Type of Mark: Fancy
Date of Acceptance: July 30, 2025
Registration Advertised: Jan. 14
For further details contact Minter Ellison.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2554488.
Disclaimer: Curated by HT Syndication.
